Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Linda Izzo"'
Vaccination with BCGΔBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG
Autor:
Michel de Jesús Aceves-Sánchez, Mario Alberto Flores-Valdez, César Pedroza-Roldán, Elizabeth Creissen, Linda Izzo, Fabiola Silva-Angulo, Clinton Dawson, Angelo Izzo, Helle Bielefeldt-Ohmann, Cristian Alfredo Segura-Cerda, Wendy López-Romero, Jorge Bravo-Madrigal, Jorge Alberto Barrios-Payán, Miguel Ángel de la Cruz, Miguel Ares, María Guadalupe Jorge-Espinoza
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract A single intradermal vaccination with an antibiotic-less version of BCGΔBCG1419c given to guinea pigs conferred a significant improvement in outcome following a low dose aerosol exposure to M. tuberculosis compared to that provided by a sin
Externí odkaz:
https://doaj.org/article/5c59aca1dc2a4630bd0accb20d8195d8
Autor:
Thomas E. Bickett, Jennifer McLean, Elizabeth Creissen, Linda Izzo, Cassidy Hagan, Antonio J. Izzo, Fabiola Silva Angulo, Angelo A. Izzo
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
The live attenuated Mycobacterium bovis strain, Bacille Calmette Guérin (BCG) is a potent innate immune stimulator. In the C57BL/6 mouse model of tuberculosis, BCG vaccination leads to a significant reduction of Mycobacterium tuberculosis burden aft
Externí odkaz:
https://doaj.org/article/ab724926653d4b2286633affba82ccfe
Autor:
Mario A. Flores-Valdez, César Pedroza-Roldán, Michel de Jesús Aceves-Sánchez, Eliza J. R. Peterson, Nitin S. Baliga, Rogelio Hernández-Pando, JoLynn Troudt, Elizabeth Creissen, Linda Izzo, Helle Bielefeldt-Ohmann, Thomas Bickett, Angelo A. Izzo
Publikováno v:
Frontiers in Microbiology, Vol 9 (2018)
Mycobacterium tuberculosis (M. tuberculosis), the causative agent of human tuberculosis (TB), is estimated to be harbored by up to 2 billion people in a latent TB infection (LTBI) state. The only TB vaccine approved for use in humans, BCG, does not c
Externí odkaz:
https://doaj.org/article/3b14c2891c0b40eb8b5aff55e0e7a1ff
Autor:
Carla Duncan, Frances B Jamieson, JoLynn Troudt, Linda Izzo, Helle Bielefeldt-Ohmann, Angelo Izzo, Carolina Mehaffy
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0179996 (2017)
Tuberculosis remains one of the most difficult to control infectious diseases in the world. Many different factors contribute to the complexity of this disease. These include the ability of the host to control the infection which may directly relate
Externí odkaz:
https://doaj.org/article/1d95f39cbb324a9d90597c5eb146040d
Vaccination with BCGΔBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG
Autor:
Jorge Barrios-Payán, César Pedroza-Roldán, Helle Bielefeldt-Ohmann, Miguel Cruz, Fabiola Silva-Angulo, Angelo Izzo, Linda Izzo, Clinton C. Dawson, María Guadalupe Jorge-Espinoza, Jorge Bravo-Madrigal, Elizabeth Creissen, Michel de Jesús Aceves-Sánchez, Wendy López-Romero, Miguel A. Ares, Cristian Alfredo Segura-Cerda, Mario Alberto Flores-Valdez
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Scientific Reports
Scientific Reports
A single intradermal vaccination with an antibiotic-less version of BCGΔBCG1419c given to guinea pigs conferred a significant improvement in outcome following a low dose aerosol exposure to M. tuberculosis compared to that provided by a single dose
Publikováno v:
Current Protocols. 1
Autor:
Elizabeth Creissen, Linda Izzo, Angelo Izzo, Fabiola Silva Angulo, Cassidy Hagan, Antonio J. Izzo, Thomas E. Bickett, Jennifer McLean
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
The live attenuated Mycobacterium bovis strain, Bacille Calmette Guerin (BCG) is a potent innate immune stimulator. In the C57BL/6 mouse model of tuberculosis, BCG vaccination leads to a significant reduction of Mycobacterium tuberculosis burden afte
Autor:
Riccardo Manganelli, Elizabeth Creissen, Linda Izzo, Stefano Casonato, Angelo Izzo, JoLynn Troudt, Helle Bielefeldt-Ohmann
Publikováno v:
Tuberculosis. 106:99-105
With more than 9 million new infections and 1.5 million deaths claimed every year, tuberculosis remains one of the major scourges of humankind. The only vaccine available against this disease, the attenuated strain Mycobacterium bovis, BCG is effecti
Autor:
Linda Izzo, Angelo Izzo, Amber Troy, Alicia Bartek, Sandra C. Esparza-Gonzalez, Elizabeth Creissen
Publikováno v:
Tuberculosis (Edinb)
Toll-Like Receptor (TLR) 9 stimulation is required for induction of potent immune responses against pathogen invasion. The use of unmethylated CpG as adjuvants in vaccines provides an excellent means of stimulating adaptive immunity. Our data demonst
Autor:
Thomas Bickett, Elizabeth Creissen, Fabiola Silva Angulo, Antonio Izzo, Linda Izzo, Angelo A Izzo
Publikováno v:
The Journal of Immunology. 202:62.12-62.12
Mycobacterium bovis Bacille Calmette Guérin (BCG) is a potent immune stimulator that activates innate and adaptive immunity. In the C57BL/6 mouse model of tuberculosis, BCG stimulated immunity causes a significant reduction of M. tuberculosis burden